2012
DOI: 10.1136/neurintsurg-2012-010321
|View full text |Cite
|
Sign up to set email alerts
|

Wingspan experience in the treatment of symptomatic intracranial atherosclerotic disease after antithrombotic failure

Abstract: This cohort of patients with symptomatic ICAD who failed antithrombotic medications benefited from angioplasty and stenting with the Wingspan system.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 13 publications
0
10
0
Order By: Relevance
“…Because of the latter properties, we use the Solitaire stent at our center to treat complex intracranial stenosis for which the Wingspan stent appears unsuited. The results of the present study indicate that deployment of a Solitaire stent with balloon angioplasty is safe and effective for complex severe intracranial stenosis with a higher technical success rate, relatively lower periprocedural complication rate, and lower ISR rate than the Wingspan stent 7 27…”
Section: Discussionmentioning
confidence: 63%
“…Because of the latter properties, we use the Solitaire stent at our center to treat complex intracranial stenosis for which the Wingspan stent appears unsuited. The results of the present study indicate that deployment of a Solitaire stent with balloon angioplasty is safe and effective for complex severe intracranial stenosis with a higher technical success rate, relatively lower periprocedural complication rate, and lower ISR rate than the Wingspan stent 7 27…”
Section: Discussionmentioning
confidence: 63%
“…Patients who failed antithrombotic therapy may benefit more from endovascular treatment than those who did not. A study that included symptomatic ICAS patients, with 95.5% (43/45) failing at least one kind of antithrombotic therapy, showed a 30 days stroke or vascular death rate of 6.6% after endovascular treatment, which was significantly better than SAMMPRIS ( 18 ).…”
Section: Three Aspects Of Factors Affect Outcomes Of Endovascular Trementioning
confidence: 98%
“…However, even after endovascular treatment, the rate of re-stenosis or occlusion was not significantly decreased compared with the medical group (25.8% vs 33.3%). A high rate of re-stenosis after PTAS with the Wingspan stent had already been reported by other researchers 16. This may be a limitation of the current endovascular technique.…”
Section: Discussionmentioning
confidence: 75%